1261869-76-4 Usage
General Description
1-oxoisoindoline-5-carbonitrile is a chemical compound with the molecular formula C10H5NO. It is a heterocyclic compound containing a five-membered ring with an oxygen and nitrogen atom, as well as a carbonitrile group. 1-oxoisoindoline-5-carbonitrile is used in organic synthesis and pharmaceutical research, and its structure makes it a potential candidate for drug development. It has been studied for its potential biological activities, including as an anticonvulsant and anti-inflammatory agent. Additionally, 1-oxoisoindoline-5-carbonitrile has been investigated for its potential use in the synthesis of other organic compounds and as a building block for the development of new materials. Overall, this chemical compound has garnered interest for its potential applications in various fields, including medicine and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 1261869-76-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,1,8,6 and 9 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1261869-76:
(9*1)+(8*2)+(7*6)+(6*1)+(5*8)+(4*6)+(3*9)+(2*7)+(1*6)=184
184 % 10 = 4
So 1261869-76-4 is a valid CAS Registry Number.
InChI:InChI=1S/C9H6N2O/c10-4-6-1-2-8-7(3-6)5-11-9(8)12/h1-3H,5H2,(H,11,12)
1261869-76-4Relevant articles and documents
Diverse, Potent, and Efficacious Inhibitors That Target the EED Subunit of the Polycomb Repressive Complex 2 Methyltransferase
Bagal, Sharan K.,Barton, Peter,Bloecher, Andrew,Borodovsky, Alexandra,Code, Erin,Fillery, Shaun M.,Gregson, Clare,Hsu, Jessie Hao-Ru,Kawatkar, Sameer P.,Li, Chengzhi,Longmire, David,Nai, Youfeng,Nash, Samuel C.,O' Donovan, Daniel H.,Pike, Andrew,Pike, Kurt G.,Rawlins, Phillip B.,Read, Jon A.,Robinson, James,Shen, Minhui,Tang, Jia,Wang, Peng,Williamson, Beth,Woods, Haley
, p. 17146 - 17183 (2021/12/06)
Aberrant activity of the histone methyltransferase polycomb repressive complex 2 (PRC2) has been linked to several cancers, with small-molecule inhibitors of the catalytic subunit of the PRC2 enhancer of zeste homologue 2 (EZH2) being recently approved fo
Degradable hydrogel under physiological conditions
-
Paragraph 0385; 0390, (2020/09/09)
The present invention discloses a hydrogel that can be degraded under physiological conditions. The hydrogel includes at least one backbone moiety and an optional crosslinking moiety, and biodegradable linkers connecting backbone moieties and crosslinking moieties can be degraded by intramolecular cyclization.
